Carani Sanjeevi
Direttore/Membro del Consiglio presso Allarity Therapeutics Europe ApS
Posizioni attive di Carani Sanjeevi
Società | Posizione | Inizio | Fine |
---|---|---|---|
Karolinska Institutet | Corporate Officer/Principal | 01/01/1996 | - |
Allarity Therapeutics Europe ApS
Allarity Therapeutics Europe ApS Pharmaceuticals: MajorHealth Technology Allarity Therapeutics Europe ApS operates as a pharmaceutical company that provides oncology products. The firm engages in diagnostics and drug development. The company was founded by Steen Meier Knudsen on August 1, 2012 and is headquartered in Hørsholm, Denmark. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Carani Sanjeevi
Precedenti posizioni note di Carani Sanjeevi
Società | Posizione | Inizio | Fine |
---|---|---|---|
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Direttore/Membro del Consiglio | 18/12/2018 | 07/10/2020 |
Independent Dir/Board Member | 18/12/2018 | 07/10/2020 | |
Center for Molecular Medicine (Sweden) | Corporate Officer/Principal | - | - |
Cadila Pharmaceuticals Sweden AB | Direttore/Membro del Consiglio | - | - |
Oncology Venture Sweden AB
Oncology Venture Sweden AB BiotechnologyHealth Technology Oncology Venture Sweden AB engages in research and development of anti-cancer drugs through its subsidiary Oncology Ventures ApS. It focuses on diagnostics and development of medicinal products for treatment of cancer. The company was founded by Peter Buhl Jensen, Steen Meier Knudsen, Nils Aage Brünner, and Ulla Hald Buhl on June 4, 2015 and is headquartered in Hørsholm, Denmark. | Direttore/Membro del Consiglio | 01/01/2015 | - |
Statistiche
Distribuzione geografica
Svezia | 4 |
Danimarca | 4 |
Posizioni
Director/Board Member | 4 |
Corporate Officer/Principal | 2 |
Independent Dir/Board Member | 1 |
Settori
Health Technology | 5 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 5 |
---|---|
Center for Molecular Medicine (Sweden) | |
Allarity Therapeutics Europe ApS
Allarity Therapeutics Europe ApS Pharmaceuticals: MajorHealth Technology Allarity Therapeutics Europe ApS operates as a pharmaceutical company that provides oncology products. The firm engages in diagnostics and drug development. The company was founded by Steen Meier Knudsen on August 1, 2012 and is headquartered in Hørsholm, Denmark. | Health Technology |
Oncology Venture Sweden AB
Oncology Venture Sweden AB BiotechnologyHealth Technology Oncology Venture Sweden AB engages in research and development of anti-cancer drugs through its subsidiary Oncology Ventures ApS. It focuses on diagnostics and development of medicinal products for treatment of cancer. The company was founded by Peter Buhl Jensen, Steen Meier Knudsen, Nils Aage Brünner, and Ulla Hald Buhl on June 4, 2015 and is headquartered in Hørsholm, Denmark. | Health Technology |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Health Technology |
Cadila Pharmaceuticals Sweden AB | Health Technology |
- Borsa valori
- Insiders
- Carani Sanjeevi
- Esperienza